Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

143
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
143
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

190
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
190
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

249
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
249
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

160
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
160
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

218
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
218
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

15
Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ECMO for patients with obesity: evidence and practice.

Intensive care medicine·2026
Same author

Regional gas exchange evaluation during ex vivo lung perfusion in a swine model of localized lung dysfunction.

Animal models and experimental medicine·2026
Same author

Definition and prognostic value of response to prone positioning in ARDS: a systematic review and meta-analysis.

Critical care (London, England)·2026
Same author

Parenting, pregnancy and work-family balance in intensive care medicine: an ESICM survey and a call for action.

Intensive care medicine·2026
Same author

Early trajectories of pulmonary hemodynamics in ARDS patients undergoing V-V ECMO: key determinants and prognostic impact.

Critical care (London, England)·2026
Same author

Health-Related Quality of Life and Mobility Levels in ICU Survivors with Heel Pressure Ulcer: An Observational Study.

Nursing reports (Pavia, Italy)·2026
Same journal

Hidden effects of dobutamine on cardiac output.

Intensive care medicine experimental·2026
Same journal

Behaviour artificial intelligence technology to support the decision-making process of continuation or withdrawal of life-sustaining therapy.

Intensive care medicine experimental·2026
Same journal

Continuous intratracheal gas suctioning combined with ventilator leak-compensation may enhance carbon dioxide removal efficiency: a proof-of-concept study using a porcine model.

Intensive care medicine experimental·2026
Same journal

Timing-dependent renal protection of dapagliflozin in endotoxemic diabetic mice by real-time GFR and biomarkers.

Intensive care medicine experimental·2026
Same journal

Improving mortality prediction in critically ill cancer patients with a multidimensional machine learning model.

Intensive care medicine experimental·2026
Same journal

Mouse models to study von Willebrand factor in inflammation: a scoping review.

Intensive care medicine experimental·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

411

Current knowledge gaps in extracorporeal respiratory support.

Tommaso Tonetti1,2, Alberto Zanella3,4, David Pérez-Torres5

  • 1Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, Bologna, Italy.

Intensive Care Medicine Experimental
|November 14, 2023
PubMed
Summary
This summary is machine-generated.

Extracorporeal life support (ECLS), including veno-venous extracorporeal membrane oxygenation (V-V ECMO) and extracorporeal carbon dioxide removal (ECCO2R), offers advanced respiratory support. Challenges in timing, equipment, and management require ongoing research for optimal patient outcomes.

Keywords:
Acute respiratory failureGas exchangeLung protective ventilationV-V ECMO

More Related Videos

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

317
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.5K

Related Experiment Videos

Last Updated: Jul 11, 2025

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

411
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

317
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.5K

Area of Science:

  • Critical Care Medicine
  • Respiratory Physiology
  • Biomedical Engineering

Background:

  • Acute respiratory failure necessitates advanced support beyond conventional ventilation.
  • Veno-venous extracorporeal membrane oxygenation (V-V ECMO) and extracorporeal carbon dioxide removal (ECCO2R) are key ECLS modalities.
  • Current ECLS technologies face limitations in size, durability, and efficiency.

Purpose of the Study:

  • To provide a comprehensive review of V-V ECMO and ECCO2R for acute respiratory failure.
  • To discuss the clinical applications, challenges, and future directions in ECLS.
  • To highlight areas for research and development in ECLS technology and management.

Main Methods:

  • Review of current literature on V-V ECMO and ECCO2R.
  • Analysis of technological advancements in oxygenators and ECLS devices.
  • Discussion of clinical management strategies, including anticoagulation and pharmacokinetics.

Main Results:

  • V-V ECMO effectively treats severe ARDS by improving gas exchange and reducing lung workload.
  • ECCO2R facilitates ultra-protective ventilation and reduces ventilatory load in moderate ARDS and COPD exacerbations.
  • Key challenges include optimal timing of initiation, equipment innovation, coagulation management, and weaning protocols.

Conclusions:

  • ECLS, encompassing V-V ECMO and ECCO2R, is a vital tool for managing severe respiratory failure.
  • Ongoing research and technological advancements are crucial for overcoming current ECLS limitations.
  • The integration of ECLS with other organ support (Extracorporeal Organ Support - ECOS) represents a future direction for critically ill patients.